Navigation Links
Newly Released Canadian Data Links Vaccines with Pervasive,Developmental Disorder

National Autism Association calls 2006 Pediatrics study fatally flawed

CHICAGO, March 07, 2007 /PRNewswire-USNewswire/ -- New findings presented yesterday at a National Autism Association meeting bolster claims that vaccines may play a role in the development of autism spectrum disorders. David Ayoub, MD presented data suggesting a correlation between mercury- containing vaccines and rates of pervasive developmental disorder (PDD), a form of autism, in Montreal. The peak rate of one in 87 children diagnosed with PDD occurred following the period of greatest exposure to the mercury- based vaccine preservative thimerosal. A flattening of the rates studied is now emerging as mercury-containing vaccines have been gradually eliminated from the routine schedule.

This new data points out flaws in a 2006 study published in the journal Pediatrics by Eric Fombonne, MD, et al, which found PDD rates continued to increase even when rates of MMR vaccination and use of mercury-containing vaccines decreased. The study population consisted of a single Montreal school board that was an Autism Center of Excellence, suggesting an over- ascertainment of regional diagnoses. Dr. Ayoub and co-authors Monica Ruscitti, BA, and F. Edward Yazbak, MD broadened the data to include all five Montreal school boards.

The earlier study also reported PDD rates in children from Montreal, but MMR coverage data was taken from Quebec City located 265km from Montreal. The researchers confirmed MMR coverage rates actually increased in Montreal along with PDD, noting a sharper rise in rates after the number of required MMR shots doubled.

The Pediatrics paper claimed there was no exposure to mercury from vaccines post-1996 although several mercury-containing vaccines were administered well beyond 1996. "It's irresponsible that such flawed data was published in a medical journal. This new information confirms a relationship between va
'"/>




Page: 1 2

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
2. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
3. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
4. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
5. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
6. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
7. ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
8. MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed with Breast Cancer
9. Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
10. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
(Date:5/17/2013)... , May 17, 2013 The power of ... important ways in which mankind depends on the plant ... Garden,s multifaceted exhibition Wild Medicine: Healing ... on view from May 18 through September 8, ... The featured exhibition,s many attractions include a re-creation ...
(Date:5/17/2013)... 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or ... Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) ... Diseases (NIAID), a division of the National Institutes ... human antibody therapeutics to combat Staphylococcus aureus ... including methicillin-resistant S. aureus (MRSA), was ...
(Date:5/17/2013)... May 17, 2013   Shareholder rights attorneys  at ... Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint ... Massachusetts .  The complaint alleges that ... Exchange Act of 1934 (the "Exchange Act") between January ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
Breaking Medicine Technology:Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
... 22 Omeros Corporation (Nasdaq: OMER ), ... products focused on inflammation and disorders of the central ... a webcast conference call Monday afternoon, October 25, 2010 ... update. Gregory A. Demopulos, M.D., chairman and chief executive ...
... ENDP ) today announced that it will present at the ... 2010, at 2:10 p.m. EDT.  Blaine Davis, vice president, corporate affairs ... There will be a live webcast and it can be ... section. About Endo Endo ...
Cached Medicine Technology:Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update 2
(Date:5/20/2013)... In celebration of National Women’s Health Week and ... The Feinstein Institute for Medical Research and ... in Science and Medicine (AWSM) , hosted its second ... business and community leaders from the region attended the ... science. , “Women face unique barriers to success ...
(Date:5/20/2013)... Posterior fossa subdural hematoma (PFSDH) is a serious and ... But with appropriate treatment, there,s an excellent chance of ... reports a study in the May issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , The results ...
(Date:5/20/2013)... Hospital emergency departments play a growing role in the ... of hospital admissions and serving increasingly as an advanced ... new RAND Corporation study. , While often targeted as ... rooms remain an important safety net for Americans who ... in slowing the growth of health care costs, according ...
(Date:5/20/2013)... it about toothpaste that transforms the sweet flavor of ... to that mysterious sensory phenomenon in colorful, animated ... Chemical Society,s award-winning Bytesize Science video series ... world,s largest scientific society, explains that the mainstay ingredients ... or SLS for short. When you brush your teeth, ...
(Date:5/20/2013)... As high schoolers prepare for final exams, teens ... -- a prescription stimulant or amphetamine -- to gain ... poll shows only one in 100 parents of teens ... a study drug., Study drugs refer to stimulant medications ... disorder (ADHD); commonly prescribed medicines in this category include ...
Breaking Medicine News(10 mins):Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2
... Kids treated more than 150 days after an Anterior Cruciate ... including medial meniscal tears, say researchers presenting at the American ... Francisco, CA. "In our research, children who had delayed ... to have an increased chance of also having a medial ...
... FRANCISCO, CA When it comes to treating people ... with the use of magnetic resonance images (MRI), according ... Society for Sports Medicine,s (AOSSM) Specialty Day in San ... sample of volunteers without any hip pain, and discovered ...
... appeared to not affect injury rates and performance in ... Orthopaedic Society for Sports Medicine,s Specialty Day in San ... an injury and enhanced performance in baseball pitchers is ... Carl W. Nissen, MD of Elite Sports Medicine and ...
... (HealthDay News) -- ,There,s little evidence linking disease severity ... in HIV-positive children and teens infected around the time ... experts were concerned that more severe HIV illness -- ... specific highly active antiretroviral therapy regimens might increase the ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, Feb. ... ago that a strange new strain of flu first appeared ... States and eventually much of the globe. The H1N1 ... it proved particularly dangerous to children and younger adults -- ...
... Dentistry at the University of Alberta is hoping its latest ... that target certain types of cancers. , The discovery ... fellow Nicolas Coquelle has shed light on what happens in ... a DNA repair enzyme called polynucleotide kinase/phosphatase, or PNKP. This ...
Cached Medicine News:Health News:Delaying ACL reconstruction in kids may lead to higher rates of associated knee injuries 2Health News:HIV Severity, Treatment Unrelated to Kids' Mental Woes: Study 2Health News:H1N1 'Swine' Flu Makes a Comeback in Mexico 2Health News:New understanding of DNA repair could eventually lead to cancer therapy 2
... is an automated microplate analyzer ... microplate techniques. Open architecture design ... many manufacturers' microplate assays and ... R.I.A. and I.F.A. methods as ...
... MAP D-Type can combine a number ... 180 microplates on a simple to ... instrument is a multifunctional stand-alone device ... larger robotic systems. Custom and standard ...
... provides a fast, accurate assessment of,patient ... patented,state-of-the-art optics yield accurate measurements of ... total hemoglobin. When,used in combination with ... gives a comprehensive and complete assessment ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
Medicine Products: